Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients

American Journal of Transplantation

Volumn 11, Issue 5, 2011, Pages 1006-1015

  Molnar, M Z ^a,b   Kovesdy, C P ^c,d   Bunnapradist, S ^e   Streja, E ^a,f   Mehrotra, R ^a,e   Krishnan, M ^g   Nissenson, A R ^g   Kalantar Zadeh, K ^a,b,f  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g DAVITA INC   (United States)

Author keywords

Cardiovascular death; delayed graft function (DGF); graft failure; hypoalbuminemia; kidney transplantation; malnutrition inflammation complex; mortality

Indexed keywords

SERUM ALBUMIN;

ADULT; ARTICLE; DELAYED GRAFT FUNCTION; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; HEMODIALYSIS PATIENT; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL MORTALITY;

ADULT; COHORT STUDIES; DIABETES COMPLICATIONS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; REGISTRIES; REGRESSION ANALYSIS; RISK; SERUM ALBUMIN; TREATMENT OUTCOME;

EID: 79955540729     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03480.x     Document Type: Article

References (48)

1. Wolfe RA, Ashby VB, Milford EL, et al,. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730.
2. Schnuelle P, Lorenz D, Trede M, Van Der Woude FJ,. Impact of renal cadaveric transplantation on survival in end-stage renal failure: Evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. J Am Soc Nephrol 1998; 9: 2135-2141. (Pubitemid 28482164)
3. Port FK, Wolfe RA, Mauger EA, Berling DP, Jiang K,. Comparison of survival probabilities for dialysis patients vs. cadaveric renal transplant recipients. JAMA 1993; 270: 1339-1343. (Pubitemid 23267894)
4. Ojo AO, Port FK, Wolfe RA, Mauger EA, Williams L, Berling DP,. Comparative mortality risks of chronic dialysis and cadaveric transplantation in black end-stage renal disease patients. Am J Kidney Dis 1994; 24: 59-64. (Pubitemid 24212977)
5. Herzog CA, Ma JZ, Collins AJ,. Long-term survival of renal transplant recipients in the United States after acute myocardial infarction. Am J Kidney Dis 2000; 36: 145-152. (Pubitemid 30432576)
6. Howard RJ, Patton PR, Reed AI, et al,. The changing causes of graft loss and death after kidney transplantation. Transplantation 2002; 73: 1923-1928. (Pubitemid 34701001)
7. Lentine KL, Brennan DC, Schnitzler MA,. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol 2005; 16: 496-506. (Pubitemid 41725147)
8. Locatelli F, Pozzoni P, Del Vecchio L,. Renal replacement therapy in patients with diabetes and end-stage renal disease. J Am Soc Nephrol 2004; 15 (Suppl 1): S25-S29. (Pubitemid 38018450)
9. Varagunam M, Finney H, Trevitt R, et al,. Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome, in kidney transplant recipients. Am J Kidney Dis 2004; 43: 502-507. (Pubitemid 38298210)
10. Fabrizii V, Winkelmayer WC, Klauser R, et al,. Patient and graft survival in older kidney transplant recipients: Does age matter? J Am Soc Nephrol 2004; 15: 1052-1060. (Pubitemid 38375325)
11. Wu C, Evans I, Joseph R, et al,. Comorbid conditions in kidney transplantation: Association with graft and patient survival. J Am Soc Nephrol 2005; 16: 3437-3444. (Pubitemid 46179346)
12. Yarlagadda SG, Coca SG, Garg AX, et al,. Marked variation in the definition and diagnosis of delayed graft function: A systematic review. Nephrol Dial Transplant 2008; 23: 2995-3003.
13. Yarlagadda SG, Coca SG, Formica RN, Jr,., Poggio ED, Parikh CR,. Association between delayed graft function and allograft and patient survival: A systematic review and meta-analysis. Nephrol Dial Transplant 2009; 24: 1039-1047.
14. Tapiawala SN, Tinckam KJ, Cardella CJ, et al,. Delayed graft function and the risk for death with a functioning graft. J Am Soc Nephrol 2010; 21: 153-161.
15. Almond PS, Matas AJ, Canafax DM,. Fixed-rate reimbursement fails to cover costs for patients with delayed graft function. Pharmacotherapy 1991; 11: 126S-129S.
16. Almond PS, Troppmann C, Escobar F, Frey DJ, Matas AJ,. Economic impact of delayed graft function. Transplant Proc 1991; 23 (1 Pt 2): 1304.
17. Rosenthal JT, Danovitch GM, Wilkinson A, Ettenger RB,. The high cost of delayed graft function in cadaveric renal transplantation. Transplantation 1991; 51: 1115-1118.
18. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, et al,. Revisiting mortality predictability of serum albumin in the dialysis population: Time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant 2005; 20: 1880-1888. (Pubitemid 41222603)
19. Stenvinkel P, Heimburger O, Paultre F, et al,. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-1911. (Pubitemid 29197978)
20. Kovesdy CP, George SM, Anderson JE, Kalantar-Zadeh K,. Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease. Am J Clin Nutr 2009; 90: 407-414.
21. Kalantar-Zadeh K, Kopple JD,. Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis 2001; 38: 1343-1350. (Pubitemid 34193125)
22. Molnar MZ, Lukowsky LR, Streja E, et al,. Blood pressure and survival in long-term hemodialysis patients with and without polycystic kidney disease. J Hypertens 2010; 28: 2475-2484.
23. Miller JE, Kovesdy CP, Norris KC, et al,. Association of cumulatively low or high serum calcium levels with mortality in long-term hemodialysis patients. Am J Nephrol 2010; 32: 403-413.
24. Miller JE, Kovesdy CP, Nissenson AR, et al,. Association of hemodialysis treatment time and dose with mortality: The role of race and gender. Am J Kidney Dis 2010; 55: 100-112.
25. Kalantar-Zadeh K, Streja E, Kovesdy CP, et al,. The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clin Proc 2010; 85: 991-1001.
26. Kalantar-Zadeh K, Miller JE, Kovesdy CP, et al,. Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients. J Bone Miner Res 2010; 25: 2448-2458.
27. Rambod M, Kovesdy CP, Bross R, Kopple JD, Kalantar-Zadeh K,. Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis. Am J Clin Nutr 2008; 88: 1485-1494.
28. Molnar MZ, Streja E, Kovesdy CP, et al,. Associations of body mass ndex and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients. Am J Transplant 2011, (in press).
29. van Ree RM, Gross S, Zelle DM, et al,. Influence of C-reactive protein and urinary protein excretion on prediction of graft failure and mortality by serum albumin in renal transplant recipients. Transplantation 2010; 89: 1247-1254.
30. Yelken BM, Gorgulu N, Caliskan Y, et al,. Comparison of nutritional status in hemodialysis patients with and without failed renal allografts. Clin Transplant 2010; 24: 481-487.
31. Sagedal S, Hartmann A, Nordal KP, et al,. Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. Kidney Int 2004; 66: 329-337. (Pubitemid 38870110)
32. Kim JM, Kim SJ, Joh JW, et al,. The risk factors for cytomegalovirus syndrome and tissue-invasive cytomegalovirus disease in liver transplant recipients who have cytomegalovirus antigenemia. Transplant Proc 2010; 42: 890-894.
33. Jassal SV, Schaubel DE, Fenton SS,. Baseline comorbidity in kidney transplant recipients: A comparison of comorbidity indices. Am J Kidney Dis 2005; 46: 136-142. (Pubitemid 40848442)
34. Chinen J, Shearer WT,. 6. Secondary immunodeficiencies, including HIV infection. J Allergy Clin Immunol 2008; 121 (2 Suppl): S388-S392; quiz S417. (Pubitemid 351172420)
35. Ross R,. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115-126.
36. Malyszko J, Malyszko JS, Pawlak K, Wolczynski S, Mysliwiec M,. Apelin, a novel adipocytokine, in relation to endothelial function and inflammation in kidney allograft recipients. Transplant Proc 2008; 40: 3466-3469.
37. van Ree RM, Oterdoom LH, de Vries AP, et al,. Circulating markers of endothelial dysfunction interact with proteinuria in predicting mortality in renal transplant recipients. Transplantation 2008; 86: 1713-1719.
38. Perico N, Cattaneo D, Sayegh MH, Remuzzi G,. Delayed graft function in kidney transplantation. Lancet 2004; 364: 1814-1827. (Pubitemid 39488068)
39. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL,. Delayed graft function: Risk factors and implications for renal allograft survival. Transplantation 1997; 63: 968-974. (Pubitemid 27173019)
40. Koning OH, van Bockel JH, Van Der Woude FJ, Persijn GG, Hermans J, Ploeg RJ,. Risk factors for delayed graft function in University of Wisconsin solution preserved kidneys from multiorgan donors. European Multicenter Study Group on organ preservation. Transplant Proc 1995; 27: 752-753.
41. Sellers MT, Gallichio MH, Hudson SL, et al,. Improved outcomes in cadaveric renal allografts with pulsatile preservation. Clin Transplant 2000; 14: 543-549.
42. Gjertson DW,. Impact of delayed graft function and acute rejection on graft survival. Transplant Proc 2002; 34: 2432. (Pubitemid 35299814)
43. Hassanain M, Tchervenkov J, Cantarovich M, et al,. Delayed graft function has an equally bad impact on deceased donor renal graft survival in both standard criteria donors and expanded criteria donors. Transplant Proc 2009; 41: 133-134.
44. Gentil MA, Alcaide MP, Algarra GR, et al,. Impact of delayed graft function on cadaveric kidney transplant outcome. Transplant Proc 2003; 35: 689-691. (Pubitemid 36338116)
45. Arias M,. Impact of the delayed graft function in hypersensitized kidney transplant patients. Transplant Proc 2003; 35: 1655-1657. (Pubitemid 37093661)
46. Boom H, Mallat MJ, de Fijter JW, Zwinderman AH, Paul LC,. Delayed graft function influences renal function, but not survival. Kidney Int 2000; 58: 859-866. (Pubitemid 30620036)
47. Marcen R, Orofino L, Pascual J, et al,. Delayed graft function does not reduce the survival of renal transplant allografts. Transplantation 1998; 66: 461-466. (Pubitemid 28415371)
48. Narayanan R, Cardella CJ, Cattran DC, et al,. Delayed graft function and the risk of death with graft function in living donor kidney transplant recipients. Am J Kidney Dis 2010; 56: 961-970.